Types of Chemotherapy Drugs that Cause Hair Loss
Most chemotherapy agents used to treat cancer are highly toxic and induce hair loss in an estimated average of 65% of cancer patients, depending on the type of drug. In fact, alopecia is one of the top three major adverse effects due to toxicity of these drugs. Although doctors and nurses tend to underestimate the tremendous psychological impact chemotherapy-induced hair loss causes cancer patients, it is a serious side effect that can negatively affect a patient’s overall cancer treatment outcome with the potential risks of depression, anxiety, and even rejection of certain chemotherapy regimens.(4)
Chemotherapy is the primary cause of a certain type of hair loss called anagen effluvium, which affects both scalp and body hair. At lower doses it can produce a telogen effluvium. The effects of chemotherapy are meant to interrupt rapidly dividing cancer cells. Unfortunately, hair in the growth phase is comprised of rapidly dividing cells too. With up to 90% of hair in the anagen phase at any given time, the hair loss can be dramatic. Typically it begins within the first few weeks of treatment and reaches its maximum loss in about two months. Hair loss caused by chemotherapy drugs is usually reversible, though it may take up to six months to start regrowth.(29, 32, 89)
Classes of Chemotherapy Drugs
Chemotherapy drugs are generally grouped into four major types, or classes. Each type carries a different risk of alopecia, but combination therapies using two or more drugs typically cause higher and more severe rates of loss.(32)
CHEMOTHERAPY DRUGS AND RISK OF HAIR LOSS |
||
---|---|---|
Antimicrotubule Agents (also known as plant alkaloids, but some are derived from bacteria)(149) |
||
Vinca alkaloids: vincristine, vinblastine, vinorelbine |
Cancers typically treated by vinca alkaloid chemotherapy drugs include:(150-152)
|
|
Taxanes: paclitaxel, docetaxel |
Cancers typically treated by taxane chemotherapy drugs include:(153, 154)
|
|
Podopyllotoxins: etoposide, teniposide |
Cancers typically treated by podopyllotoxin chemotherapy drugs include:(155)
|
|
Camptothecan analogs: irinotecan, topotecan |
Cancers typically treated by camptothecan analog chemotherapy drugs include chemoresistant:(156, 157)
|
|
Topoisomerase Inhibitors |
||
Type I: irinotecan, topotecan |
Cancers typically treated by type I topoisomerase inhibitor chemotherapy drugs include chemoresistant:(156, 157)
|
|
Type II: amsacrine, doxorubicin, etoposide, etoposide phosphate, teniposide |
Cancers typically treated by type II topoisomerase inhibitor chemotherapy drugs include:(155, 158)
|
|
Alkylating agents |
||
Nitrogen mustards: mechlorethamine, chlorambucil, cyclophosphamide, ifosfamide, melphalan |
Nitrogen mustard chemotherapy drugs are used to treat many different cancers since they do not work on specific cancer cell phases.Types of cancers used for include:(159)
|
|
Nitrosoureas: streptozocin (Zanosar®), carmustine, and lomustine |
Nitrosourea chemotherapy drugs are used to treat many different cancers since they do not work on specific cancer cell phases.Types of cancers used for include:(159)
|
|
Triazines: dacarbazine, temozolomide |
Triazine chemotherapy drugs are used to treat many different cancers since they do not work on specific cancer cell phases.Types of cancers used for include:(159)
|
|
Platinum drugs: carboplatin, cisplatin, oxaliplatin |
Platinum-based chemotherapy drugs are used to treat many different cancers since they do not work on specific cancer cell phases.Types of cancers used for include:(159)
|
|
Antimetabolites |
||
5-fluorouracil, capecitabine, 6-mercaptopurine,methotrexate, gemcitabine, cytarabine, fludarabine, pemetrexed | Antimetabolite chemotherapy drugs are used to treat:(159)
|
Chemo Drugs Unlikely to Cause Hair Loss
The good news is that even within some of the classes with higher risk of hair loss, there are some chemotherapy drugs where hair loss is unusual. These include:(32)
CHEMOTHERAPY DRUGS LESS LIKELY TO CAUSE HAIR LOSS | |
---|---|